Development of a vaccine to prevent Japanese encephalitis: a brief review
- PMID: 20360904
- PMCID: PMC2840557
- DOI: 10.2147/ijgm.s6281
Development of a vaccine to prevent Japanese encephalitis: a brief review
Abstract
Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed.
Keywords: Japanese encephalitis; concept; development; prevention; vaccine.
References
-
- Wiwanitkit V. Japanese encephalitis. J Ped infect Dis. 2007;4(2):183–192.
-
- Halstead SB, Jacobson J. Japanese encephalitis. Adv Virus Res. 2003;61:103–138. - PubMed
-
- Watanabe T. Japanese encephalitis. Nippon Rinsho. 2003;61(Suppl 2):95–99. - PubMed
-
- Solomon T. Recent advances in Japanese encephalitis. J Neurovirol. 2003;9(2):274–283. - PubMed
-
- Kawakatsu S. Encephalitis and psychosis. Ryoikibetsu Shokogun Shirizu. 2003;(40):303–306. - PubMed
LinkOut - more resources
Full Text Sources